United States· US:71610-910_35bbb655-19e3-00c2-e063-6394a90afbe3
Tamsulosin hydrochloride
A tamsulosin product containing tamsulosin hydrochloride, registered in United States by Aphena Pharma Solutions - Tennessee, LLC. The same ATC class is registered in 17 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Tamsulosin is registered in 17 of 19 countries.
Countries holding a registration under ATC G04CA02 (tamsulosin), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 11 of them publish a price we can compare per daily dose
Tamsulosin · ATC G04CA02
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of tamsulosin costs, country by country.
Normalised to the WHO defined daily dose (0.4 mg), the median price runs from $0.17 in France to $1.11 in Switzerland — a ×6.5 gap.
- 4 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Tamsulosin · price per daily dose (0.4 mg)
USD · FX 28 Sept 2026
- CH Switzerland$1.11
- ES Spain$0.42
- IT Italy$0.25
- FR France$0.17
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- TAMSULOSIN HYDROCHLORIDE
- Manufacturer
- Aphena Pharma Solutions - Tennessee, LLC
- Country
- United States (US)
- ATC code
- G04CA02
- ATC class
- Tamsulosin
- Defined daily dose
- 0.4 mg, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 10
- ndc11716109103030 CAPSULE in 1 BOTTLE (71610-910-30)
- ndc11716109105360 CAPSULE in 1 BOTTLE (71610-910-53)
- ndc11716109106090 CAPSULE in 1 BOTTLE (71610-910-60)
- ndc117161091070120 CAPSULE in 1 BOTTLE (71610-910-70)
- ndc117161091080180 CAPSULE in 1 BOTTLE (71610-910-80)
- ndc1171610-910-30
- ndc1171610-910-53
- ndc1171610-910-60
- ndc1171610-910-70
- ndc1171610-910-80
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
311 interactions on record for tamsulosin.
Graded by severity as the source publishes them — 9 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Tamsulosin · interactions on record
311 records
- 9 severe
- 101 moderate
- 1 minor
- 168 info
Most severe, free to view
- KetoconazoleH02CA03severe
- ClarithromycinJ01FA09severe
- KetoconazoleJ02AB02severe
- Darunavir and cobicistatJ05AR14severe
32 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under G04CA02
Tamsulosin, as other registers publish it.
- PolandAdatamAdamed Pharma S.A.
- PolandAdatam XRAdamed Pharma S.A.
- United KingdomAlphacard MR 400microgram capsulesRatiopharm UK Ltd
- ItalyANTUNESFIDIA SPECIALTY S.R.L.
- ItalyANTUNESFIDIA SPECIALTY S.R.L.
- PolandApo-TamisAurovitas Pharma Polska Sp. z o.o.
- CanadaAPO-TAMSULOSIN CRAPOTEX INC
- CanadaAURO-TAMSULOSIN CRAURO PHARMA INC
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/af8a70a1-ae77-47f7-bf74-263fe9f356b1 GET /v1/drugs/af8a70a1-ae77-47f7-bf74-263fe9f356b1?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": ".4",
"substance": "TAMSULOSIN HYDROCHLORIDE",
"productndc": "71610-910",
"dosage_form": "CAPSULE",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "ANDA078801",
"marketing_category": "ANDA"
}See everything about tamsulosin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.